Traduction de «sans autre explication » (Français → Anglais) :

Other decisions (Adopted without discussion. In the case of legislative acts, votes against or abstentions are indicated. Decisions containing statements which the Council has decided may be released to the public or explanations of vote are asterisked; the statements and explanations of vote in question may be obtained from the Press Office.)

Death occurring less than 24 hours from onset of symptoms, not otherwise explained

explanatory statement | explanation from the Federal Council | explanatory pamphlet

explanatory notes to the combined nomenclature | Explanatory notes to the Combined Nomenclature of the European Communities | Explanatory notes to the Combined Nomenclature of the European Union | CNENs [Abbr.]

explanation-based learning

explanation-based learning | EBL [Abbr.]

Person consulting for explanation of investigation findings

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, ...[+++] clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

predictor (1) | causal variable (2)

independent data

an explanation of the key methodologies and assumptions used by the valuer when performing the valuation, how sensitive the valuation is to the choices of methodologies and assumptions and, where feasible, an explanation of how those methodologies and assumptions differ from those used for other relevant valuations including any preliminary resolution valuations.

an explanation, where feasible, why the valuation differs from other relevant valuations, including the resolution valuations conducted in accordance with Commission Delegated Regulation (EU) 2018/345 or other regulatory or accounting valuations.

Where the UCITS invests a substantial proportion of its assets in other UCITS or other collective investment undertakings as referred to in Article 50(1)(e) of Directive 2009/65/EC, the description of the objectives and investment policy of that UCITS in the key investor information document shall include a brief explanation of how the other collective undertakings are to be selected on an ongoing basis.

A Party seeking recognition of its regionalisation decision by the other Party shall notify its measures with full explanation and supporting data for its determinations and decisions, as guided by the relevant FAO International Standards for Phytosanitary Measures, including No 4 "Requirements for the establishment of Pest Free Areas", No 8 "Determination of Pest Status in an area", and other International Standards for Phytosanitary Measures as the Parties deem appropriate.